It sounds like patients have only been recruited from the Melbourne site so far, things might pickup pace when Sydney get up and running.
“The trial is overseen by Dr Susan Mathers of Calvary Health Care, Bethlehem, Statewide Progressive Neurological Disease Service, Melbourne and will include a second trial site headed by Professor Dominic Rowe of the Centre for Motor Neurone Disease Research Faculty of Medicine and Health Research at Macquarie University, Sydney.”
- Forums
- ASX - By Stock
- Ann: First Patient of Cohort 2 Dosed in MND Trial
NUZ
neurizon therapeutics limited
Add to My Watchlist
3.23%
!
16.0¢

It sounds like patients have only been recruited from the...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
16.0¢ |
Change
0.005(3.23%) |
Mkt cap ! $78.76M |
Open | High | Low | Value | Volume |
16.0¢ | 16.0¢ | 15.5¢ | $92.10K | 590.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 23 | 16.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.5¢ | 193530 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 23 | 0.160 |
2 | 160027 | 0.155 |
7 | 161777 | 0.150 |
1 | 300000 | 0.145 |
1 | 100000 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.165 | 193530 | 4 |
0.170 | 811665 | 3 |
0.175 | 29411 | 1 |
0.180 | 93615 | 2 |
0.185 | 144500 | 4 |
Last trade - 15.45pm 04/07/2025 (20 minute delay) ? |
Featured News
NUZ (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online